Cargando…

Circulating Zinc-α2-glycoprotein levels and Insulin Resistance in Polycystic Ovary Syndrome

The aim of study was to assess the relationship between zinc-α2-glycoprotein (ZAG) and androgen excess with insulin resistance in polycystic ovary syndrome (PCOS) women. 99 PCOS women and 100 healthy controls were recruited. Euglycemic-hyperinsulinemic clamp (EHC) was preformed to assess their insul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lai, Yerui, Chen, Jinhua, Li, Ling, Yin, Jingxia, He, Junying, Yang, Mengliu, Jia, Yanjun, Liu, Dongfang, Liu, Hua, Liao, Yong, Yang, Gangyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4867572/ https://www.ncbi.nlm.nih.gov/pubmed/27180914 http://dx.doi.org/10.1038/srep25934

Ejemplares similares

Adiponectin/(FBG × FIns) as a predictor of insulin sensitivity and metabolic syndrome in patients with polycystic ovary syndrome
por: Xu, Xiaohui, et al.
Publicado: (2016)

Circulating ANGPTL8 Is Associated with the Presence of Metabolic Syndrome and Insulin Resistance in Polycystic Ovary Syndrome Young Women
por: Pu, Danlan, et al.
Publicado: (2019)

Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor Increases Circulating Zinc-Α(2)-Glycoprotein Levels in Patients with Type 2 Diabetes
por: Liao, Xin, et al.
Publicado: (2016)

Zinc-α(2)-Glycoprotein Is Associated With Insulin Resistance in Humans and Is Regulated by Hyperglycemia, Hyperinsulinemia, or Liraglutide Administration: Cross-sectional and interventional studies in normal subjects, insulin-resistant subjects, and subjects with newly diagnosed diabetes
por: Yang, Mengliu, et al.
Publicado: (2013)

Effect of C-reactive protein deficiency on insulin resistance reversal in rats with polycystic ovary syndrome through augmented leptin action
por: Li, Ke, et al.
Publicado: (2023)

Serum Fetuin-A levels are increased and associated with insulin resistance in women with polycystic ovary syndrome
por: Liu, Sha, et al.
Publicado: (2020)

Circulating betatrophin is associated with insulin resistance in humans: cross-sectional and interventional studies in vivo and in vitro
por: Wang, Han, et al.
Publicado: (2017)

Elevated Circulating Fetuin-B Levels Are Associated with Insulin Resistance and Reduced by GLP-1RA in Newly Diagnosed PCOS Women
por: Mokou, Mani, et al.
Publicado: (2020)

Elevated circulating GPHB5 levels in women with insulin resistance and polycystic ovary syndrome: A cross-sectional study and multiple intervention studies
por: Wang, Yanping, et al.
Publicado: (2022)

Duodenal GLP-1 signaling regulates hepatic glucose production through a PKC-δ-dependent neurocircuitry
por: Yang, Mengliu, et al.
Publicado: (2017)

Circulating CTRP7 Is a Potential Predictor for Metabolic Syndrome
por: Hu, Wenjing, et al.
Publicado: (2021)

Follicular hyperandrogenism and insulin resistance in polycystic ovary syndrome patients with normal circulating testosterone levels
por: Li, Andi, et al.
Publicado: (2018)

Circulating zinc-α2-glycoprotein levels are low in newly diagnosed patients with metabolic syndrome and correlate with adiponectin
por: Lei, Lu, et al.
Publicado: (2017)

NAMPT knockdown attenuates atherosclerosis and promotes reverse cholesterol transport in ApoE KO mice with high-fat-induced insulin resistance
por: Li, Shengbing, et al.
Publicado: (2016)

Liraglutide Increases FGF-21 Activity and Insulin Sensitivity in High Fat Diet and Adiponectin Knockdown Induced Insulin Resistance
por: Yang, Mengliu, et al.
Publicado: (2012)

Effects of Short-Term Continuous Subcutaneous Insulin Infusion on Fasting Plasma Fibroblast Growth Factor-21 Levels in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
por: Yang, Mengliu, et al.
Publicado: (2011)

Serum Soluble Glycoprotein 130 Concentration Is Inversely Related to Insulin Sensitivity in Women With Polycystic Ovary Syndrome
por: Nikolajuk, Agnieszka, et al.
Publicado: (2010)

Gut ghrelin regulates hepatic glucose production and insulin signaling via a gut-brain-liver pathway
por: Lin, Yao, et al.
Publicado: (2019)

Polycystic ovary syndrome and circulating inflammatory markers
por: Zafari Zangeneh, Farideh, et al.
Publicado: (2017)

Insulin resistance and fertility in polycystic ovary syndrome.
por: Fica, S, et al.
Publicado: (2008)

Serum Leptin Level in Women with Polycystic Ovary Syndrome: Correlation with Adiposity, Insulin, and Circulating Testosterone
por: Chakrabarti, J
Publicado: (2013)

CTRP7 Is a Biomarker Related to Insulin Resistance and Oxidative Stress: Cross-Sectional and Intervention Studies In Vivo and In Vitro
por: Li, Kejia, et al.
Publicado: (2022)

Major determinants of circulating myostatin in polycystic ovary syndrome
por: Arpaci, Haldun
Publicado: (2019)

Identification of Differentially Expressed MicroRNAs in the Ovary of Polycystic Ovary Syndrome with Hyperandrogenism and Insulin Resistance
por: Lin, Lin, et al.
Publicado: (2015)

Nesfatin-1 Action in the Brain Increases Insulin Sensitivity Through Akt/AMPK/TORC2 Pathway in Diet-Induced Insulin Resistance
por: Yang, Mengliu, et al.
Publicado: (2012)

New markers of insulin resistance in polycystic ovary syndrome
por: Polak, K., et al.
Publicado: (2016)

Limitations of insulin resistance assessment in polycystic ovary syndrome
por: Lewandowski, Krzysztof C, et al.
Publicado: (2018)

Proteomics analysis of potential serum biomarkers for insulin resistance in patients with polycystic ovary syndrome
por: Li, Li, et al.
Publicado: (2020)

Association between polycystic ovarian morphology and insulin resistance in women with polycystic ovary syndrome
por: Lee, Jeong Eun, et al.
Publicado: (2023)

The alterations of circulating mucosal-associated invariant T cells in polycystic ovary syndrome
por: Zhou, Hong, et al.
Publicado: (2022)

Circulating SCUBE1 levels in women with polycystic ovary syndrome
por: Erol, Onur, et al.
Publicado: (2018)

Levels of circulating insulin cell-free DNA in women with polycystic ovary syndrome – a longitudinal cohort study
por: Udesen, Pernille Bækgaard, et al.
Publicado: (2019)

Defective insulin signaling and the protective effects of dimethyldiguanide during follicular development in the ovaries of polycystic ovary syndrome
por: Wang, Fan, et al.
Publicado: (2017)

Effects of insulin-sensitizing agents and insulin resistance in women with polycystic ovary syndrome
por: Hwang, Kyu Ri, et al.
Publicado: (2013)

Is Insulin Resistance an Intrinsic Defect in Asian Polycystic Ovary Syndrome?
por: Lee, Hyejin, et al.
Publicado: (2013)

Insulin-Sensitizers, Polycystic Ovary Syndrome and Gynaecological Cancer Risk
por: Lauretta, Rosa, et al.
Publicado: (2016)

Markers of insulin resistance in Polycystic ovary syndrome women: An update
por: Amisi, Chantal Anifa
Publicado: (2022)

Insulin Metabolism in Polycystic Ovary Syndrome: Secretion, Signaling, and Clearance
por: Herman, Rok, et al.
Publicado: (2023)

Circulating Levels of CILP2 Are Elevated in Coronary Heart Disease and Associated with Atherosclerosis
por: Hu, Wenjing, et al.
Publicado: (2020)

Prolactin Is Associated With Insulin Resistance and Beta-Cell Dysfunction in Infertile Women With Polycystic Ovary Syndrome
por: Yang, Haiyan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_76fmakc7ahls3rl2i0kanma8u8